Discovery Laboratories News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

12.04.17	And Now There Is One….Second Consecutive Win For Toyota - World Green Car (PR Newswire)
19.04.16	HRTX Abuzz, ILMN Disappoints, STEM Grows, LLY Abandons TTHI's Diabetes Drug (RTTNews)
15.10.14	Discovery Labs Reaches Strategic Collaboration With Battelle - Quick Facts (RTTNews)
18.06.14	CANF In For The Long Haul, CLTX Awaits Busy Q4, DSCO Gets Richer, ECYT Slumps (RTTNews)
17.06.14	Discovery Labs Gets $1.9 Mln Fast Track Grant To Support AEROSURF Study (RTTNews)
07.05.14	Discovery Labs Gets 1 New US Patent, Notices Of Allowance For 2 Patents (RTTNews)
25.03.14	Discovery Labs Appoints John Tattory As SVP And CFO - Quick Facts (RTTNews)
13.03.14	Discovery Laboratories Q4 Loss Widens - Quick Facts (RTTNews)
12.11.13	Discovery Laboratories Gets FDA Clearance For Phase II Study Of AEROSURF (RTTNews)
17.10.13	Discovery Labs Announces IND Submission for AEROSURF® (PR Newswire)
09.10.13	Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray (PR Newswire)
08.10.13	Discovery Lab: USPTO Issues New Patent Supporting AEROSURF Development Program (RTTNews)
08.10.13	Discovery Labs Announces Notice of Allowance for a U.S. Patent Supporting the AEROSURF® Development Program (PR Newswire)
07.10.13	ATOS Crushed, CVM Gets Grace Period, DSCO Soars, MNOV On The Watch (RTTNews)
04.10.13	Discovery Labs Says FDA Approves Surfaxin Updated Product Specifications (RTTNews)
04.10.13	Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications (PR Newswire)
05.09.13	Discovery Labs to Present at Stifel Healthcare Conference 2013 (PR Newswire)
25.07.13	Discovery Labs to Report Second Quarter 2013 Results and Hold Conference Call on Thursday, August 8, 2013 (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	510.00	3.09 %	K V
UBS Group	29.96	1.97 %	K V
Zurich Insur Gr	537.60	1.55 %	K V
Logitech Intl	80.34	1.47 %	K V
Swiss Life Hldg	717.00	1.36 %	K V
Kuehne+Nagel Int	200.90	0.45 %	K V
Swisscom	509.00	0.30 %	K V
Alcon	75.84	0.18 %	K V
Nestle	73.66	-0.67 %	K V
CieFinRichemont	139.05	-0.82 %	K V